GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 2,497 | 2,364 | 2,740 | 2,050 | 2,968 |
| Cost of Goods | 1,345 | 1,216 | 1,496 | 1,140 | 2,430 |
| Gross Profit | 1,152 | 1,148 | 1,244 | 910 | 538 |
| Operating Expenses | 4,686 | 3,125 | 2,513 | 1,923 | 4,421 |
| Operating Income | -3,189 | -1,761 | -773 | -873 | -3,453 |
| Interest Expense | 26 | 101 | 14 | 18 | 14 |
| Other Income | 108 | -836 | 9 | 69 | -28 |
| Pre-tax Income | -3,107 | -2,698 | -778 | -822 | -3,495 |
| Income Tax | 2 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -3,109 | -2,698 | -778 | -822 | -3,495 |
| Net Income Discontinuous | N/A | N/A | -13 | N/A | N/A |
| Net Income | $-3,109 | $-2,698 | $-791 | $-822 | $-3,495 |
| EPS Basic Total Ops | -0.07 | -0.10 | -0.04 | -0.08 | -0.36 |
| EPS Basic Continuous Ops | -0.07 | -0.10 | -0.04 | -0.08 | -0.36 |
| EPS Diluted Total Ops | -0.07 | -0.10 | -0.04 | -0.08 | -0.36 |
| EPS Diluted Continuous Ops | -0.07 | -0.10 | -0.04 | -0.08 | -0.36 |
| EBITDA(a) | $-3,035 | $-934 | $-596 | $-591 | $-3,041 |